ScanSource: The Guidance Got Cut in February — Then Came the Biggest Deal in Company History

There's an investor weakness that hits especially disciplined investors — because it feels like rigor: the snapshot trap. It works like this: a company posts a disappointing quarter, cuts guidance, the stock falls below book value — and you form a picture. A reasoned, data-backed picture. The problem isn't the picture itself; it's that you never update it. A quarterly report is a snapshot, not a movie — and whoever keeps only the February snapshot misses what happened on the same set by August.

ScanSource, Inc. (NASDAQ: SCSC) offers an unusually clean example, because both snapshots are on the public record. On February 5, 2026, management cut its full-year guidance after large deals "broke into smaller pieces" and slipped into the next quarter; one analyst on the call dryly noted the stock was now trading below book value. Six months later, on August 20, 2026, the same company reported full-year revenue above its cut guidance, free cash flow well above both promises it had made along the way — and, on the same day, the largest acquisition in its history, worth $220.5 million. The stock jumped 9.7% that day. So here's the deal: we'll read three earnings calls and two annual reports that sit between those two dates — and along the way work out how much of the profit jump is real growth and how much is buybacks. What you do with it is your call.

What ScanSource actually does — not a manufacturer, a wholesaler with a brokerage business on the side

ScanSource was incorporated in South Carolina in 1992, went public in 1994, and is still headquartered in Greenville, South Carolina. The company doesn't manufacture anything itself — it's a technology distributor: it buys hardware and software from roughly 500 vendors, bundles it into ready-to-deploy solutions, and resells it through roughly 25,000 channel sales partners — small and midsize IT solution providers that don't want, or can't sustain, a direct purchasing relationship with every individual vendor. Picture it this way: if Cisco, Zebra Technologies or Honeywell are the manufacturers, ScanSource is the wholesaler in between that handles inventory, financing, technical support and bundling so the local IT reseller doesn't have to juggle 500 separate supply contracts.

The business runs through two segments that work very differently. Specialty Technology Solutions is the classic hardware business: barcode and mobility solutions, point-of-sale systems, payment terminals, physical security (video surveillance, access control), communications equipment and networking gear — the last category explicitly including "artificial intelligence ('AI') infrastructure products," as the annual report puts it. The segment generated roughly $3.12 billion in revenue in fiscal 2026, nearly 97% of the company — but margins are thin, because hardware distribution is a volume business.

The second segment, Intelisys & Advisory, is structurally the opposite: it brokers cloud, security, communications and "Managed AI" services for a commission, without delivering the underlying services itself. Revenue is reported "netted down" as a result — only the commission counts, not the full contract value of the cloud deals it brokers. At just $101.1 million in fiscal 2026 revenue, the segment is tiny next to the hardware business — but its operating margin runs around 40%, versus low single digits for the hardware segment. Keep this picture in mind: ScanSource is 97% a low-margin hardware wholesaler and 3% a high-margin brokerage business — and the company's growth story hinges on how fast that mix shifts. That tension runs through the rest of this analysis.

One detail worth flagging up front: the annual report names two suppliers without hedging — "Products from two suppliers, Cisco and Zebra, each constituted more than 10% of our net sales for the fiscal year ended June 30, 2026." If you want to know more about one of those two names, we covered Zebra Technologies itself in a separate deep dive — a supplier ScanSource visibly depends on too.

How the stock landed on our desk — an annual report and an acquisition on the same day

The trigger is impossible to miss: on August 20, 2026, ScanSource filed three things with the SEC at once — its Form 10-K for the fiscal year ended June 30, 2026, a current report (Form 8-K, Item 2.02) with fourth-quarter results, and, in the same 8-K under Item 1.01, the purchase agreement for MicroAge. An annual report and a $220-million strategic move on the same day is an unusual amount of news for a company this size.

MicroAge is an IT solutions integrator and managed services provider with roughly 2,400 clients and more than 200 employees, focused on cloud, data center, cybersecurity, IT operations and help desk services. The purchase price: $220.5 million in cash at closing, plus $3 million and $6.8 million held in escrow for post-closing purchase-price adjustments and indemnification claims, respectively. Closing is expected in the quarter ending September 30, 2026, subject to antitrust clearance under the Hart-Scott-Rodino Act and other customary conditions. CEO Mike Baur put it this way in the results release: "We're also excited about our agreement to acquire MicroAge, which we believe will accelerate growth, expand margins, and adds new services capabilities."

Important context: the fiscal 2027 outlook issued the same day (6 to 10% revenue growth, $158-165 million adjusted EBITDA, at least $85 million free cash flow) does not yet include MicroAge — it describes the existing business, not the combined one. How well MicroAge integrates will only show up in future reports.

What management promised — and what happened

The real reason this stock is worth a close look isn't the acquisition day itself, but what three earnings calls before it reveal. ScanSource keeps its quarterly analyst calls on the public record, and reading them back to back tells a story with a genuine turning point.

In August 2025, alongside its fiscal 2025 annual report, management issued its first guidance for the new fiscal year 2026. On November 6, 2025, on the first-quarter call, CFO Steve Jones reaffirmed it unchanged: revenue growth to $3.1 to $3.3 billion, adjusted EBITDA of $150 to $160 million, free cash flow of at least $80 million. Confidence was still intact.

Then came February 5, 2026, the second-quarter call — and the tone audibly shifted. Revenue and gross profit had grown in both segments, but slower than expected, and unexpected costs (freight, mix, a customer-specific bad-debt reserve) had squeezed margins. CEO Baur explained the core of the problem this way:

"We saw large deals get broken up into smaller pieces. And so as they're rolling out, they're not happening normally, and we saw this even last quarter. […] Implicit in our adjusted guidance is that we do need the large deals to resume, and we believe that, that will happen."

— Michael Baur, Chairman & CEO, ScanSource, Inc., second-quarter fiscal 2026 earnings call, February 5, 2026

Management then cut full-year guidance: revenue from $3.1-3.3 billion to $3.0 to $3.1 billion, adjusted EBITDA from $150-160 million to $140 to $150 million. Only the free-cash-flow target — at least $80 million — held. How sour sentiment had turned by that point shows in an aside from Raymond James analyst Adam Tindle on the same call: the stock, he noted, was now trading "below book value." For a company with positive operating cash flow and no balance-sheet problems, that's a clear signal of how skeptical the market had become.

On May 7, 2026, on the third-quarter call, the turn arrived. Revenue grew 9% in the quarter, led by networking and security. CFO Jones summed it up plainly: "When we look at our full year outlook that we gave last quarter, we said that we would need some large deals coming in, and we had growth projected for the second half. Q3 delivered on that." Management reaffirmed the February-cut revenue and EBITDA range and raised its free-cash-flow target to at least $90 million. Asked the obvious follow-up — whether some of the strong quarter had simply been pulled forward from Q4 — Jones answered: "We don't believe that we saw material pull forwards in our Q3 results."

Then, on August 20, 2026, the provisional end of the story: actual full-year revenue of $3,226.1 million landed above the February-cut range and just above the midpoint of the original August 2025 range ($3.2 billion). Adjusted EBITDA of $151.5 million beat the cut range and landed almost at the low end of the original one. The sharpest contrast was in free cash flow: $113.8 million — well above both the initial $80 million floor and the $90 million floor raised in May. The chart below traces that path from first guidance to actual result:

One caveat, in fairness: a full transcript of the August 20, 2026 earnings call was not yet available at the time of this analysis — the figures and CEO quote above come from the same-day, SEC-mandated results release, which matches the call's content but contains no analyst Q&A. Still, what the three fully reviewed calls and this release show is clear: guidance was rightly cut in February 2026 — and comfortably cleared again by August 2026.

The numbers over the years — a recovery, not a record

Looking only at the fourth quarter — revenue up 17.3%, GAAP earnings per share up 40.9% — you could get the impression ScanSource is on an uninterrupted growth path. The five-year series tells a more sober story:

Revenue was $3,787.7 million in 2023, fell for two straight years — to $3,259.8 million (2024) and $3,040.8 million (2025) — and recovered to $3,226.1 million in 2026. That's a solid comeback, but a comeback: the company remains roughly 15% below its 2023 revenue. Net income traces the same curve on a smaller scale: $89.8 million (2023), $77.1 million (2024), $71.5 million (2025), $78.9 million (2026). Anyone extrapolating the latest quarter's pop across the full year overstates the momentum — the year-over-year check shows a recovery from a two-year decline, not a new growth phase.

What actually shifted in this series is the mix, not just the volume: gross margin rose from 13.4% (2025) to 13.6% (2026) because the share of recurring, commission-based revenue in gross profit grew from 32.8% to 33.7%. The higher-margin Intelisys & Advisory segment is growing relative to the hardware business — slowly, but visibly. And that is exactly where the first uncomfortable truth begins: part of 2026's much-discussed profit jump has nothing to do with that operating progress at all.

Uncomfortable truth #1: earnings per share grew twice as fast as earnings

This analysis just cited two numbers that look like they should move together — and don't. GAAP net income rose 10.2% in fiscal 2026 to $78.873 million. Diluted earnings per share rose 21.3% in the same year, to $3.64. Twice as fast — on essentially the same underlying business. How?

The answer sits one line below: diluted weighted-average shares fell from 23.839 million (2025) to 21.692 million (2026) — a 9.0% drop in a single year. Over two years, against 25.222 million in fiscal 2024, that's a 14.0% decline. The reason is no secret: ScanSource repurchased $97.9 million of its own stock in fiscal 2026, after $106.5 million the year before — more than $200 million over two years spent pulling its own shares out of the market.

The math checks out almost exactly: earnings up 10.2%, spread across 9.0% fewer shares, mechanically produces roughly 21% higher EPS — nearly identical to the reported 21.3%. This is not an accounting trick — buybacks are a legal, widely used form of returning capital, and ScanSource funded them from operating cash, not new debt. But it's a distinction worth knowing before reading "EPS grew by more than a fifth" as "the business grew by more than a fifth." The more honest number for operating progress is the line above the share count: up 10.2% — solid, but noticeably less dramatic than the headline suggests.

For completeness: the smaller, classic one-time items on the balance sheet — restructuring costs, a legal settlement, lingering effects of the 2023 cyberattack — ran in the low single-digit millions in fiscal 2026 and, on balance, were a slight drag rather than a boost to adjusted earnings. They don't explain the earnings jump; the buyback effect does.

Uncomfortable truth #2: the largest segment's goodwill has only 2 percent of cushion left

This number appears in no press release and wasn't mentioned on the earnings call — it's buried in the annual report's notes to the financial statements, under goodwill. A quick detour for context: when ScanSource has acquired companies in the past, a residual amount was regularly left over that couldn't be assigned to specific machines, contracts or inventory — that residual is carried on the balance sheet as goodwill and must be tested for impairment every year. If a segment's estimated fair value falls below its carrying value, the company must write it down — a direct hit to earnings.

At ScanSource, the latest test shows a split picture. In the small, high-margin Intelisys & Advisory segment ($71.0 million of goodwill), estimated fair value exceeded carrying value by more than 100% — a thick, reassuring cushion. In the large hardware segment, Specialty Technology Solutions, which carries $173.9 million — more than 70% of the company's total goodwill of $244.9 million — that same cushion was just 2%. The auditor flagged exactly this point as a "critical audit matter" — a label reserved, in the auditor's own words, for matters that "involved our especially challenging, subjective, or complex judgments."

To be fair and precise: no impairment has occurred in fiscal 2026 or either of the two prior years, and a 2% cushion doesn't mean a write-down is imminent. Fair value is estimated using a model of future cash flows built on assumptions about growth, margin and the discount rate — assumptions that shift modestly from year to year without anything changing in the underlying business. Still, the cushion is remarkably thin for a segment that accounts for 97% of company revenue. Should Specialty Technology Solutions growth fall short of the 6-to-10% range guided for fiscal 2027, or should the discount rate rise with higher interest rates, an impairment at the next annual test — scheduled for fiscal Q4 2027 — stops being a purely theoretical scenario.

Uncomfortable truth #3: the high-margin segment is growing slower than management wants it to

The third uncomfortable truth isn't a single number — it's a question-and-answer exchange, and that's exactly why it deserves attention: management tends to speak less guardedly in the moment than in prepared remarks. On the third-quarter call, on May 7, 2026, analyst Keith Housum of Northcoast Research pressed CEO Baur on whether Intelisys new orders had grown at all year over year — picking up on a concern analyst Gregory Burns of Sidoti & Company had already raised earlier in the same call, about whether roughly eighteen months of investment in Intelisys & Advisory had produced the hoped-for acceleration:

"I assume that order growth didn't grow for the quarter year over year?" — "No, we didn't say that. Our belief is that we are doing everything we've said we're going to do, but we want to go faster. We don't believe it's growing at the rate we would like to see."

— Keith Housum (Northcoast Research) and Michael Baur, Chairman & CEO, ScanSource, Inc., third-quarter fiscal 2026 earnings call, May 7, 2026

That's a rare, plainly stated admission: the company's highest-margin segment — roughly 40% adjusted EBITDA margin versus low single digits for hardware — isn't delivering new orders as fast as management itself wants, despite roughly eighteen months of targeted investment (including a new sales team under Ken Mills, hired in 2024). In response, ScanSource used the same call to announce a new "Converged Communications" unit under Katherine White, aimed at putting the traditional communications hardware business and Intelisys cloud brokerage under one combined sales team for the first time.

That reorganization is a reasonable response — but it is a response to a goal already missed more than once, and its effect can only be assessed in future quarters. For investors, the takeaway is this: the high-margin growth story that part of this stock's valuation rests on is, as of this analysis, a delayed promise, not a proven result.

What the stock costs

Every figure below carries the data date August 20, 2026 and should be read as an order of magnitude, not a daily price. The closing price that day was $56.39 — up 9.7% from the prior close of $51.42, driven by the same-day release of annual results and the MicroAge deal. The 52-week range ran from $33.76 to $66.78 — closer to the top than the bottom, but well below the year's high.

With 20,142,812 shares outstanding (10-K cover page, as of August 17, 2026), that puts market capitalization at roughly $1.136 billion. The price-to-earnings ratio on GAAP diluted EPS ($3.64) is roughly 15.5; on the company's preferred non-GAAP EPS ($4.24) it's roughly 13.3. The gap comes mainly from stripping out amortization of acquired intangibles — a common, but not consequence-free, adjustment.

More telling for a company carrying its own debt is enterprise value (market cap plus debt minus cash): roughly $1.136 billion plus $101.4 million of debt minus $88.4 million of cash, or about $1.149 billion. Against fiscal 2026 adjusted EBITDA of $151.5 million, that's an enterprise-value-to-EBITDA multiple of roughly 7.6 — not an especially expensive level for a low-margin but growing, lightly indebted technology distributor, but not one that simply ignores an open question like the thin goodwill cushion in the largest segment either.

Opportunities and risks at a glance

What speaks for ScanSource:

• Guidance was met and beaten by year-end. After the February 2026 cut, actual revenue ($3,226.1M), adjusted EBITDA ($151.5M) and especially free cash flow ($113.8M) all landed above the cut range and both prior floor promises of $80M and $90M.
• A solid, lightly indebted balance sheet. $910.8 million of equity against just $101.4 million of debt and $88.4 million of cash (June 30, 2026); the company is funding buybacks and the MicroAge down payment from its own cash generation, without visible strain.
• The higher-margin part of the business is growing relative to hardware distribution. The share of recurring revenue in gross profit rose to 33.7% in fiscal 2026 (from 32.8%); Q4 grew 17.3%, the fastest in years.
• MicroAge adds higher-margin services — cloud, data center, cybersecurity — for $220.5 million cash, fundable without visible balance-sheet stress.
• Consistent capital return. $97.9 million of buybacks in fiscal 2026, more than $200 million over two years — the diluted share count fell 14.0%.

What speaks against it:

• A 2% goodwill cushion in the largest segment. Specialty Technology Solutions carries $173.9 million of goodwill with only a 2% fair-value cushion — flagged by the auditor as a critical audit matter.
• Roughly half of EPS growth is a buyback effect, not operating growth. Net income rose 10.2%; EPS rose 21.3% — about 11 of those 21.3 percentage points are mechanically explained by the 9.0% decline in share count.
• The high-margin segment is delivering slower than promised. Management itself admitted in May 2026 that Intelisys new-order growth wasn't accelerating as hoped; the response — a new sales unit — is still unproven.
• Revenue remains roughly 15% below its 2023 level — fiscal 2026 is a recovery from a two-year decline, not a new growth cycle.
• MicroAge hasn't closed yet and isn't in the fiscal 2027 outlook. Closing is subject to antitrust clearance; integration costs and risks are unquantified as of this analysis.
• Supplier concentration. Cisco and Zebra Technologies each accounted for more than 10% of net sales in fiscal 2026 — losing either relationship would be a real hit.

A human verdict

Back to the snapshot trap from the opening. Anyone who stopped paying attention in February 2026 — guidance cut, stock below book value, audible analyst skepticism on the call — would have had a plausible, well-reasoned picture. And they would still have been wrong, because the August 2026 snapshot shows a company that cleared its own, already-lowered bar by year-end while simultaneously announcing the largest acquisition in its history. Both photos are true. Neither is the whole picture.

That's exactly why it pays to look past the headline, whichever direction it points. The 21.3% per-share earnings jump is real — but roughly half of it comes from fewer shares, not more profit. The 2% goodwill cushion in the largest segment is real — but it hasn't triggered a write-down yet, only a watch item for next year. The unmet promise at Intelisys is real — but it's an execution risk, not an existential one, for a company with $910.8 million of equity and $88.4 million of cash.

What's left is a distributor with thin hardware margins and a growing, high-margin side business that's supposed to grow faster than it has so far — and a management team that publicly corrected its own guidance and publicly cleared it again. Whether that's a sign of the kind of honesty that earns trust, or a pattern that could repeat at the next stumble, is for you to decide. The question this analysis leaves you with isn't "Is ScanSource a buy?" but: Do you trust a management team that had to cut guidance once to hit it the next time — even with a $220 million integration underway at the same time? What you do with that is your decision. And that's exactly how it should be.

If you want to see how another company handles buybacks when they tip into excess, our Papa John's deep dive is the counterexample: there, $1.1 billion of buybacks pushed shareholders' equity into negative territory. At ScanSource, there's no sign of that — the buybacks here are a footnote on the balance sheet, not a structural problem.

Sources

• Form 10-K for fiscal year 2026, ScanSource, Inc., filed August 20, 2026 (SEC EDGAR, CIK 0000918965)
• Form 8-K filed August 20, 2026 — Item 1.01 (MicroAge purchase agreement) and Item 2.02 with Q4/FY2026 results release
• Form 8-K filed August 17, 2026, Item 5.02 — retirement of director Peter C. Browning
• Form 8-K filed May 29, 2026, Item 5.02 — elimination of the CIO role held by Rachel Hayden
• Form 10-Q for the quarter ended March 31, 2026, filed May 7, 2026
• Form 10-Q for the quarter ended December 31, 2025, filed February 5, 2026
• Form 10-Q for the quarter ended September 30, 2025, filed November 6, 2025
• Form 10-K for fiscal year 2025, filed August 21, 2025
• Earnings call transcripts: first- (2025-11-06), second- (2026-02-05) and third-quarter (2026-05-07) fiscal 2026 calls, official transcripts via ScanSource, Inc.'s investor relations site.
• Full SEC filing history for ScanSource, Inc.: EDGAR overview (sec.gov)
• Fundamental data (market capitalization, valuation multiples, price history; as of August 20, 2026), reconciled against the SEC filings.

Transparency & disclaimer: This article is a journalistic review of publicly available information and is not investment advice, not a regulated financial analysis, and not a solicitation to buy or sell any security. Equity investments carry substantial risk, including total loss of capital. All figures are drawn from the source documents linked above and carry the date noted in the text; accuracy and completeness are not guaranteed. The author holds no position in ScanSource stock as of publication.